Connect with us

Technology

IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis

Published

on

The launch of the Catalyst® Pancreatic Lipase Test demonstrates IDEXX’s Technology for Life strategy and will provide veterinarians with quantitative results at the point-of-care in less than 10 minutes 

WESTBROOK, Maine, June 4, 2024 /CNW/ — IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of the Catalyst® Pancreatic Lipase Test, a single-slide solution for canine and feline patients suspected of pancreatitis. With the innovative load-and-go workflow of the Catalyst analyzers, the test can run effortlessly alongside chemistry profiles, leading to a faster path to diagnosis and enhanced patient outcomes. The Catalyst Pancreatic Lipase Test will be available in the U.S. and Canada this September, with a global rollout to the over 70,000 Catalyst installed base planned to begin in the fourth quarter of 2024.

Pancreatitis is a common disease among cats and dogs, and while treatable, it can prove fatal if not caught early. Diagnosing pancreatitis can be difficult due to its nonspecific symptoms and subtle clinical signs, including vomiting and weight loss, which are among the 10 most frequently recorded clinical signs in primary care clinics.1 Now, with the Catalyst Pancreatic Lipase Test, veterinarians can receive quantitative results in under 10 minutes. By delivering quantitative diagnostic insights during the patient visit, the new test empowers veterinarians to confidently confirm or rule out pancreatitis and immediately begin treatment, saving crucial time and improving patient outcomes.

“The Catalyst Pancreatic Lipase Test marks the tenth menu addition launched for the Catalyst platform since 2012, reinforcing our commitment to extend the clinical value and diagnostic capabilities of our technologies,” said Jay Mazelsky, President and Chief Executive Officer of IDEXX. “We are pleased to deliver a highly requested test, which will streamline the diagnostic workflow and equip veterinarians with the necessary clinical insights for prompt action.”

The Catalyst Pancreatic Lipase Test, coupled with VetConnect® PLUS software, provides a critical solution for the long-term management of pancreatitis patients due to the chronic nature of the disease. VetConnect PLUS allows for seamless integration of historical data and test results, enabling efficient patient progress evaluation and treatment response.

“The Catalyst Pancreatic Lipase Test is the first test to use dry chemistry slide technology that specifically measures pancreatic lipase and correlates with the IDEXX Reference Laboratories Spec cPL® and Spec fPL® tests* to provide the most accurate, quantitative results patient-side for dogs and cats,” said Jörg M. Steiner, Dr.med.vet., PhD, DACVIM-SA, DECVIM-CA, AGAF, Texas A&M University.†

New Catalyst SmartQC Control
In the fourth quarter of 2024, the Catalyst platform will be further enhanced with the launch of the Catalyst® SmartQC® Control, a load-and-go quality control testing system that is 90% faster than current methods.2 The Catalyst SmartQC Control offers an intuitive workflow that takes less than 15 minutes, ensuring quality control is run consistently without compromising staff productivity. These enhancements will be delivered through IDEXX SmartService™ Solutions, a cloud-based software that supports in-house instruments and powers seamless upgrades for new tests and features.

Please visit idexx.com for more information on the Catalyst Pancreatic Lipase Test and Catalyst SmartQC Control.

About IDEXX
IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500® Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit: www.idexx.com.

Note Regarding Forward-Looking Statements
This news release contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as “expects,” “may,” “anticipates,” “intends,” “would,” “will,” “plans,” “believes,” “estimates,” “should,” “project,” and similar words and expressions. These forward-looking statements are intended to provide our current expectations or forecasts of future events; are based on current estimates, projections, beliefs, and assumptions; and are not guarantees of future performance. Actual events or results may differ materially from those described in the forward-looking statements. These statements are subject to risks, uncertainties, assumptions, and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by IDEXX pursuant to United States securities laws contain discussions of some of these risks and uncertainties. IDEXX assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers are advised to review IDEXX’s filings with the United States Securities and Exchange Commission (which are available from the SEC’s EDGAR database at sec.gov and via IDEXX’s website at idexx.com).

1Robinson NJ, Dean RS, Cobb M, Brennan ML. Investigating common clinical presentations in first opinion small animal consultations using direct observation. Vet Rec. 2015;176(18):463. doi:10.1136/vr.102751
*The Spec cPL Test for dogs and the Spec fPL Test for cats measure the level of pancreas-specific lipase in the blood: www.idexx.com/en/veterinary/reference-laboratories/pancreatic-health.
†Dr. Steiner has received compensation from time to time for consulting services he has provided to IDEXX.
2Data on file at IDEXX Laboratories, Inc. Westbrook, Maine USA.

View original content to download multimedia:https://www.prnewswire.com/news-releases/idexx-expands-test-menu-for-the-catalyst-platform-to-support-veterinarians-globally-in-diagnosing-pancreatitis-302162411.html

SOURCE IDEXX Laboratories, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MediSun Energy and Guangdong Beijing Enterprises Shixi Technology Announce Global Distributorship for Advanced SBR-AGS Municipal Wastewater Solutions, Securing Exclusive Distribution in Malaysia and Saudi Arabia

Published

on

By

GUANGZHOU, China, Aug. 6, 2026 /PRNewswire/ — MediSun Planet Pte Ltd (“MediSun Energy”), a leader in integrated water technology and advanced circular solutions, today announced a landmark global distributorship with Guangdong Beijing Enterprises Shixi Technology Co., Ltd. Under this strategic agreement, MediSun Energy secures global distribution rights for the company’s flagship Sequential Batch Reactor – Aerobic Granular Sludge (SBR-AGS) municipal wastewater technology, including exclusive distribution rights across Malaysia and comprehensive strategic cooperation in the Kingdom of Saudi Arabia.

By fusing MediSun Energy’s cutting-edge plant design and core systems engineering with the formidable operational heritage of Guangdong Beijing Enterprises Shixi Technology—one of the top three water environmental enterprises in the world—the two organizations are spearheading a monumental shift in environmental infrastructure. Working hand-in-hand on joint plant design, MediSun Energy will provide comprehensive in-market engineering support to localize plant designs, ensuring full compliance with regional environmental standards, local civil constraints, and municipal utility interfaces.

By integrating high-efficiency SBR-AGS biological processes into standardized, modular engineering formats, the combined solution solves the most pressing bottlenecks facing modern utilities: severe urban land scarcity, long civil construction timelines, high energy demands, and strict nutrient discharge limits.

Key technical highlights of the SBR-AGS modular solution lineup include:

Biomimetic Honeycomb Modular Systems: Engineered for compact and permanent municipal needs (5,000 m³/d module scale), utilizing a prefabricated hexagonal “beehive” weathering steel structure that enables rapid on-site assembly within 15–35 days, while achieving total nitrogen removal up to 85% and biological phosphorus removal exceeding 90%.Large-Scale Modular Wastewater Treatment Complexes: Designed for major municipal infrastructure handling up to 50,000 m³/d per unit, seamlessly integrating biochemical treatment, magnetic flocculation, and UV disinfection into an aesthetic, low-profile footprint. Operating at an ultra-compact 0.2 m²/m³, it delivers 30–50% energy savings and 10–20% capital cost reductions with a deployment cycle of just 60–90 days.

Joseph Chua, President & Co-Founder of MediSun Planet Pte Ltd, stated: “Municipalities across Southeast Asia, the Middle East, and globally are seeking immediate, scalable solutions to expand wastewater treatment capacity while meeting aggressive decarbonization and footprint goals. Traditional concrete construction can no longer keep pace with rapid urbanization. By leading the engineering and plant design alongside Guangdong Beijing Enterprises Shixi Technology—and leveraging their massive plant management expertise as one of the world’s top three water environmental leaders—we are delivering a game-changing, plug-and-play pathway that turns years of civil construction into weeks of modular deployment across key markets like Malaysia and Saudi Arabia.”

Junfang Zhou (周俊芳), General Manager of Guangdong Beijing Enterprises Shixi Technology Co., Ltd., added: “Guangdong Beijing Enterprises Shixi Technology Co., Ltd. has consistently set global benchmarks in biological wastewater treatment and large-scale plant operations. Partnering closely with MediSun Energy allows us to combine our deep operational heritage, world-class SBR-AGS technological legacy, and plant management experience with MediSun’s agile plant design, engineering strength, and expanding global market presence. Together, we are redefining modern water infrastructure with low-carbon, highly efficient modular plants engineered for the future.”

The agreement accelerates the commercial rollout of decentralized municipal wastewater infrastructure, providing utilities and industrial parks worldwide with a proven, rapidly deployable pathway toward low-carbon, space-efficient wastewater management.

About MediSun Energy
MediSun Energy is a Singapore-headquartered water infrastructure company that delivers water as a product: factory-built, modular plants deployed in weeks and run by AI. Its platform spans clean water, brine recovery, compact sewage treatment and portable water systems, serving government and industrial programmes across the Gulf and Southeast Asia.

About Guangdong Beijing Enterprises Shixi Technology Co., Ltd.
BE SHIXI TECH is a leading high-tech water enterprise specializing in water supply, advanced biological wastewater treatment, reclaimed water, modular product innovation, and high-efficiency equipment manufacturing. With end-to-end capabilities spanning R&D, design, manufacturing, delivery, and rapid response, the company delivers low-carbon, integrated turnkey solutions, customized process packages, and full-station equipment integration for municipal and industrial applications worldwide — meeting comprehensive project needs in performance, efficiency, and sustainability.

View original content to download multimedia:https://www.prnewswire.com/news-releases/medisun-energy-and-guangdong-beijing-enterprises-shixi-technology-announce-global-distributorship-for-advanced-sbr-ags-municipal-wastewater-solutions-securing-exclusive-distribution-in-malaysia-and-saudi-arabia-302844559.html

SOURCE MEDISUN PLANET PTE. LTD.

Continue Reading

Technology

iSearchSolution Explores the Impact of AI on Modern SEO Services

Published

on

By

NEW DELHI, Aug. 6, 2026 /PRNewswire/ — As AI has reshaped almost every aspect of doing business, especially in Digital marketing, it has created the urgency to reframe SEO approaches. It raises the demand for enhanced search visibility, pushing brands toward smarter, intent-led SEO strategies.

To understand the core shift, the iSearchSolution in-house team conducted 50+ queries across ChatGPT, Claude AI, Perplexity, and Google Gemini. The queries were targeted to understand how ChatGPT cites company names and how Gemini produces overviews. According to the team, the New SEO algorithms no longer chase rankings; they look for recognition. 

Key findings of the research:

Google’s overview provides a 45- to 50-word summary of the query, smartly compiled from multiple sources. Technical SEO must be strong and clean. If a web page takes more than one second, one can reduce conversions by up to 7%.Technical SEO techniques must align with one’s project goals.Content should be published weekly.Domain authority matters a lot.Don’t mindlessly insert a keyword; it must be focused on search intent and people’s queries. 

As a leading SEO company in India, they focus not just on SERP positions but on building a digital network to create positive signals. They are not empowering brands for one, but for 50+ LLMs. Their AI SEO services are designed to be consistent with structural changes in information: how it appears, interacts with, and is ultimately trusted.

“I have observed the digital marketing industry reinvent itself completely four or five times. Each time, the agencies that survived were not those that found the new shortcut but those that understood the new logic and implemented it strategically. Our research confirmed that something the broader industry is now recognizing: the question has changed. We are no longer fighting for ‘how do I rank? It is about ‘Is my brand recognized as the right answer?’ Those require fundamentally different strategies,” said Deelip Kumar, Founder and CEO of iSearchSolution.

Kumar added a note of urgency for companies that have delayed addressing this shift. “Every month, a competitor earns AI citations, and you do not; their recognition signal in those systems compounds. Over time, this gap becomes harder to close, even with increased marketing spend.”

The digital ecosystem is no longer a library of links; it is a cognitive interface where information becomes instant insight. Platforms like ChatGPT serve 800 million active users and handle more than 2 billion queries daily. So, content creation needs to be more focused and planned because the goal is no longer just to be found, but to be recognized as a trusted leader.

Media Contact:
info@isearchsolution.com
+91-9871312382

About iSearchSolution

Founded in 2010, iSearchSolution is a 360-degree digital marketing agency that offers AI-driven search engine solutions. The company understands that the search era has shifted from keywords to conversational queries, and has updated its services accordingly. Apart from content marketing, pay-per-click advertising also works for Answer Engine Optimization, Generative Engine Optimization, and AI SEO services.

Over the past 15 years, the agency has delivered organic growth programs for clients across the healthcare, automotive, e-commerce, and logistics sectors in India and internationally.

For more details, visit https://www.isearchsolution.com/

 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/isearchsolution-explores-the-impact-of-ai-on-modern-seo-services-302843733.html

Continue Reading

Technology

IFI TECHSOLUTIONS ACHIEVES MICROSOFT AZURE CLOUD SECURITY SPECIALIZATION

Published

on

By

Recognition underscores enterprise-scale Azure security and governance capabilities for modern cloud environments

MUMBAI, India, Aug. 6, 2026 /PRNewswire/ — IFI Techsolutions Limited (“IFI Techsolutions”), a global cloud solutions and managed services provider, today announced that it has achieved the Microsoft Azure Cloud Security specialization, demonstrating its expertise in helping organizations secure, govern, and manage cloud environments on Microsoft Azure.

Awarded to Microsoft partners that meet rigorous standards for technical expertise, customer success, and delivery excellence, the specialization validates the company’s ability to design and implement security-first Azure environments aligned with enterprise and regulatory requirements.

The recognition reflects proven capabilities in identity and access management, threat protection, security monitoring, and cloud governance, enabling organizations worldwide to strengthen cyber resilience, reduce risk exposure, and establish secure foundations for digital transformation.

The company has demonstrated this approach across diverse enterprise environments. For a large real estate enterprise, IFI Techsolutions helped restore a customer-facing digital platform following a security incident through breach assessment, remediation, and continuous monitoring. In the financial services sector, the company deployed a centralized security operations framework powered by Microsoft Sentinel, enabling real-time monitoring, improved threat detection, automated response workflows, and stronger incident governance. Together, these engagements demonstrate IFI Tech’s ability to manage complex security operations at scale.

Puneet Bajaj, CTO, IFI Techsolutions, said:

“As enterprises continue to accelerate cloud adoption, security and governance must be foundational to every cloud strategy. This specialization validates our ability to help organizations establish secure Azure landing zones, implement Zero Trust controls, strengthen identity governance, and modernize security operations through Microsoft-native platforms.”

IFI Techsolutions remains focused on advancing its Azure security capabilities and helping enterprises build resilient, governed, and future-ready digital platforms.

About IFI Techsolutions Limited

Founded in 2013, IFI Techsolutions Limited is a global cloud solutions and managed services company headquartered in India, with operations across the United States, United Kingdom, Australia, Singapore, Canada, the UAE, New-Zealand, and Ireland. The company delivers cloud transformation, AI-led analytics, cybersecurity, and modern workplace solutions, enabling enterprises to accelerate digital innovation and business agility. With 680+ cloud projects delivered for more than 370 clients globally, 150+ Microsoft certifications, and over 120,000 consulting hours across 40+ countries, IFI Techsolutions combines deep technology expertise with a customer-centric approach to deliver secure, scalable, and outcome-driven digital transformation, with responsible AI, automation, and governance.

Media Contact
IFI Techsolutions Limited
Email: pr@ifi.tech 
Website: https://ifi.tech 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/ifi-techsolutions-achieves-microsoft-azure-cloud-security-specialization-302843995.html

Continue Reading

Trending